Blog

Postpartum depression (PPD) is a serious mood disorder that can affect women after childbirth. Unlike the more common and temporary "baby blues," which typically resolve within two weeks, postpartum depression can last much longer and significantly impact a mother’s ability to care for herself and her baby. Learn more.

A patient must receive essential treatment for a brain tumor, even during an evacuation warning for the raging Pacific Palisades fire in 2025.

The third Wednesday of each July is Glioblastoma Awareness Day. Glioblastoma (GBM) is a complex and invasive form of brain cancer, presenting difficulties in its treatment. Learn more about GMB, clinical trials and the Cancer Moonshot.

With nearly two decades of nonprofit management and fundraising experience, Melissa B. Coleman, Esq, Vice President of the PNI Foundation (PNIF), is an expert at building programmatic research teams in support of neurosciences.

At Pacific Neuroscience Institute® (PNI) we achieved many milestones in 2022 and continue to make positive impacts in neuroscience clinical care, research, and education.

Jennifer Bramen, PhD, is dedicated to improving the lives of patients through patient-centered technology at Pacific Brain Health Center.

Pacific Neuroscience Institute (PNI) located at Providence Saint John's Health Center, has activated a new psilocybin clinical trial and has begun participant enrollment.

At Pacific Neuroscience Institute, we are looking forward to what lies ahead with fresh excitement. Neurological diseases do not stop and neither have we.

Clinical trials are research studies that play a critical role in the advancement of clinical and medical knowledge about disease. At Pacific Neuroscience Institute (PNI), there are a number of upcoming and ongoing trials for patients with various neurological conditions.

Pacific Neuroscience Institute Foundation proudly sponsored Alzheimer's LA's 2021 40th anniversary event, Making Memories Festival.